ロード中...

Hepatocellular carcinoma with extrahepatic metastasis: Are there still candidates for transarterial chemoembolization as an initial treatment?

BACKGROUND AND AIM: Currently, sorafenib is indicated for hepatocellular carcinoma (HCC) with extrahepatic metastasis (EHM), and many other systemic agents are becoming available. However, a few HCC patients with EHM still undergo transarterial chemoembolization (TACE) for intrahepatic tumor control...

詳細記述

保存先:
書誌詳細
出版年:PLoS One
主要な著者: Kim, Jihye, Sinn, Dong-Hyun, Choi, Moon Seok, Kang, Wonseok, Gwak, Geum-Youn, Paik, Yong-Han, Lee, Joon Hyeok, Koh, Kwang Cheol, Paik, Seung Woon
フォーマット: Artigo
言語:Inglês
出版事項: Public Library of Science 2019
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6405107/
https://ncbi.nlm.nih.gov/pubmed/30845192
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0213547
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!